Feedback systems and methods for renal denervation utilizing balloon catheter
US-2016015452-A1 · Jan 21, 2016 · US
US10245429B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10245429-B2 |
| Application number | US-201815946919-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 6, 2018 |
| Priority date | Apr 8, 2002 |
| Publication date | Apr 2, 2019 |
| Grant date | Apr 2, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods and apparatus are provided for renal neuromodulation using a pulsed electric field to effectuate electroporation or electrofusion. It is expected that renal neuromodulation (e.g., denervation) may, among other things, reduce expansion of an acute myocardial infarction, reduce or prevent the onset of morphological changes that are affiliated with congestive heart failure, and/or be efficacious in the treatment of end stage renal disease. Embodiments of the present invention are configured for percutaneous intravascular delivery of pulsed electric fields to achieve such neuromodulation.
Opening claim text (preview).
We claim: 1. A method for catheter-based renal denervation of a hypertensive human patient, the method comprising: intravascularly positioning a distal region of a catheter within a renal artery associated with a kidney of the patient; and at least partially ablating target neural tissue innervating the kidney of the patient via ultrasound energy from the catheter, wherein the ultrasound energy is delivered via an ultrasound transducer carried by a shaft of the catheter, wherein at least partially ablating the target neural tissue results in a therapeutically beneficial reduction in blood pressure of the patient. 2. The method of claim 1 , further comprising removing the catheter from the patient after at least partially ablating the target neural tissue via the ultrasound energy to conclude the procedure. 3. The method of claim 1 wherein at least partially ablating the target neural tissue innervating the kidney further results in a therapeutically beneficial reduction in central sympathetic overactivity of the patient. 4. The method of claim 1 wherein the ultrasound energy is unfocused ultrasound energy. 5. The method of claim 1 wherein the ultrasound energy is high frequency ultrasound energy. 6. The method of claim 1 wherein intravascularly positioning a distal region of a catheter within a renal artery comprises intravascularly positioning the catheter over a guidewire. 7. The method of claim 1 , further comprising monitoring a parameter of the catheter and/or tissue within the patient before and during delivery of ultrasound energy. 8. The method of claim 7 , further comprising altering delivery of ultrasound energy in response to the monitored parameter. 9. The method of claim 1 wherein the distal region of the catheter further comprises an expandable centering element, and wherein the method further comprises transforming the centering element between a low-profile delivery configuration and an expanded configuration after intravascularly positioning the distal region of the catheter within the renal artery and before delivering the ultrasound energy via the ultrasound transducer. 10. The method of claim 9 wherein the expandable centering element comprises a balloon. 11. A method, comprising: intravascularly advancing an energy delivery element carried by a catheter within renal vasculature of a human patient and proximate to renal nerves of the patient; and delivering unfocused ultrasound energy via the energy delivery element, wherein the ultrasound energy inhibits neural traffic along the renal nerves to and/or from a kidney of the patient, wherein inhibiting the neural traffic along the renal nerves results in a therapeutically beneficial reduction in blood pressure of the patient. 12. The method of claim 11 wherein inhibiting neural traffic along the renal nerves via the ultrasound energy comprises blocking afferent and/or efferent renal nerve activity. 13. The method of claim 11 wherein a distal portion of the catheter further comprises an expandable positioning element, and wherein intravascularly advancing an energy delivery element within renal vasculature of the patient comprises positioning the catheter within a renal artery of the patient via the expandable positioning element before delivering the unfocused ultrasound energy via the energy delivery element. 14. The method of claim 13 wherein the expandable positioning element comprises an inflatable balloon. 15. The method of claim 11 , further comprising intravascularly removing the catheter and energy delivery element from the patient after delivering the unfocused ultrasound energy to conclude the procedure. 16. The method of claim 11 wherein inhibiting neural traffic along the renal nerves via the ultrasound energy comprises reducing renal sympathetic nerve activity of the kidney of the patient. 17. The method of claim 11 wherein inhibiting neural traffic along the renal nerves via the ultrasound energy comprises denervating the kidney of the patient.
having a flexible, catheter-like structure, e.g. for heart ablation (A61B18/1477 takes precedence) · CPC title
with automatic adjustment · CPC title
Urinary tract · CPC title
for enhancing the absorption properties of tissue, e.g. by electroporation · CPC title
having a basket shaped structure · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.